KJ's Gene Therapy (Clinical Trial)

Funding Details
Awarder
RSS - feeds.arstechnica.com
Date Award
May 19, 2025
Vertical
Health
Funding URL
View Funding Page

Company Info
Traction
The treatment has shown positive results in a 6-month-old patient, with improvements in health and weight, and has been presented at a major medical conference.
Company Description
KJ's Gene Therapy is focused on developing personalized CRISPR gene-editing therapies for ultra-rare genetic mutations, providing rapid treatment solutions for patients with life-threatening conditions.
Market
Gene Editing and Therapy
Location
Philadelphia, Pennsylvania, USA

Links
Back to Home Back to Health Deals View Funding Announcement